| | | | | |
NAUT Nautilus Biotechnolgy, Inc. Common Stock | $1,9050 | -4,75% | $254,15M | $525,85K | |
OTLK Outlook Therapeutics, Inc. Common Stock | $1,7150 | +0,29% | $254,08M | $1,39M | |
SIDU Sidus Space, Inc. Class A Common Stock | $2,6770 | +2,57% | $254,08M | $3,60M | |
GLO Clough Global Opportunities Fund | $6,0070 | +1,13% | $254,03M | $23,81K | |
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares | $4,1240 | -2,74% | $253,89M | $39,18K | |
FULC Fulcrum Therapeutics, Inc. Common Stock | $3,6920 | -2,84% | $253,20M | $120,81K | |
IKT Inhibikase Therapeutics, Inc. Common Stock | $1,8560 | -2,83% | $252,18M | $61,91K | |
FCT First Trust Senior Floating Rate Income Fund II | $9,6550 | -0,46% | $252,03M | $17,29K | |
ATGL Alpha Technology Group Limited Class A Ordinary Shares | $11,4000 | -0,61% | $251,62M | $1,52K | |
ACRE Ares Commercial Real Estate Corporation | $4,4750 | -0,78% | $250,21M | $75,27K | |
SCII SC II Acquisition Corp. Class A ordinary share | $10,1580 | +1,08% | $249,22M | $4,000 | |
USAU U.S. Gold Corp. Common Stock | $14,6650 | -2,69% | $248,67M | $42,91K | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | $5,3750 | +2,19% | $248,39M | $25,20K | |
EVGO EVgo Inc. Class A Common Stock | $1,8050 | +2,56% | $248,26M | $414,66K | |
QADR QDRO Acquisition Corp. Class A Ordinary Shares | $9,9690 | +0,44% | $248,12M | $16,00K | |
